Evaluation of molecular breast imaging in women undergoing myocardial perfusion imaging with Tc-99m sestamibi

Journal of Women's Health

Volumn 21, Issue 7, 2012, Pages 730-738

  Hruska, Carrie B ^a   Rhodes, Deborah J ^a   Collins, Douglas A ^a   Tortorelli, Cindy L ^a   Askew, J Wells ^a   O'Connor, Michael K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; BREAST DISEASE; BREAST HYPERPLASIA; BREAST LESION; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MOLECULAR BREAST IMAGING; MOLECULAR DIAGNOSIS; MYOCARDIAL PERFUSION IMAGING; NEEDLE BIOPSY; PHARMACOLOGIC STRESS TESTING; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BIOPSY; BREAST; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; RADIOPHARMACEUTICALS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TREATMENT OUTCOME;

EID: 84863687336     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3267     Document Type: Article

References (31)

1. Humphrey LL, Helfand M, Chan BKS, et al. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:347-360.
2. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;38:168-175.
3. Buist DSM, Porter PL, Lehman C, et al. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004;96:1432-1440.
4. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:8469-8476.
5. O'Connor MK, Rhodes D, Hruska C. Molecular breast imaging. Expert Rev Anticancer Ther 2009;9:1073-1080.
6. Rhodes DJ, O'Connor MK, Phillips SW, et al. Molecular breast imaging: A new technique for the reliable detection of small breast tumors. Mayo Clinic Proc 2005;80:24-30.
7. O'Connor MK, Phillips SW, Hruska CB, et al. Molecular breast imaging: Advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J 2007;13:3-11.
8. Hruska CB, Phillips SW, Whaley DH, et al. Molecular breast imaging:Use of a dual-head dedicated gamma camera to detect small breast tumors. Am J Roentgenol 2008;191:1805-1815.
9. D'Orsi CI, Bassett LW, Berg WA, et al. Breast imaging reporting and data system, BI-RADS: Mammography, 4th ed. Reston, VA: American College of Radiology, 2003.
10. Rhodes DJ, Hruska CB, Phillips SW, et al. Dedicated dualhead gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology 2011;258: 106-118.
11. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-236.
12. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;2:75-89.
13. Holman BL, Jones AG, Lister-James J, et al. A new Tc-99m labeled myocardial imaging agent, hexakis (t-butylisonitrile) technetium (1) [Tc-99m TBI]: Initial experience in the human. J Nucl Med 1984;25:1350-1355.
14. Wackers FJTh, Berman DS, Maddahi J, et al. Technetium 99m hexakis 2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-311.
15. Piwnica-Worms D, Holman BL. Editorial: Noncardiac applications of hexakis (alkylisonitrile) technetium-99m complexes. J Nucl Med 1990;31:1166-1167.
16. Newcombe RG. Two-sided confidence intervals for the single proportion: Comparison of seven methods. Stat Med 1998;17:857-872.
17. Rhodes DJ, Hruska CB, Maxwell RW, Conners AL, O'Connor MK. Low-dose molecular breast imaging with Tc-99m sestamibi for screening in women with dense breasts [Abstract]. J Nucl Med 2011;52:671.
18. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: Analysis of health benefits and costeffectiveness. Ann intern Med 2011;155:10-20.
19. Gur D, Sumkin JH, Rockette HE, et al. Changes in breast cancer detection and mammography recall rates after the introduction of a computer-aided detection system. J Natl Cancer Inst 2004;96:185-190.
20. National Program of Cancer Registries. United States Cancer Statistics-1999-2006 cancer incidence and mortality data. Available at apps.nccd.cdc.gov/uscs/
21. Luo J, Margolis KL, Wactawski-Wende J, et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: A prospective cohort study. BMJ 2011;342:d1016.
22. Phipps AI, Chlebowski RT, Prentice R, et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:454-463.
23. Society for Women's Health Research. Women's fear of heart disease has almost doubled in three years, but breast cancer remains most feared disease. Available at www.women shealthresearch.org/site/News2?page = NewsArticle&id = 5459&news-iv-ctrl = 0&abbr = press- Washington, DC: Society for Women's Health Research, 2005.
24. Nuclear medicine: Market summary report. Des Plains, IL: IMV Medical Information Division, 2008: IV19-IV30
25. Marwick TH, Shaw LJ, Lauer MS, et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 1999;106:172-178.
26. Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-666.
27. O'Connor MK, Hruska CB, Weinmann A, et al. Development of radiation dose reduction techniques for cadmium zinc telluride detectors in molecular breast imaging. Proc SPIE 2010;7806:780603.
28. Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 2007; 14:1315-1323.
29. Fleming RM. Mitochondrial uptake of sestamibi distinguishes between normal, inflammatory breast changes, precancers, and infiltrating breast cancer. Integr Cancer Ther 2002;1:229-237.
30. Bailey SL, Bronislava MS, Plevritis SK. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years. J Natl Cancer Inst 2010;102:1-9.
31. Pisano E, Hendrick RE, Yaffe MJ, et al. Diagnostic accuracy of digital versus film mammography: Exploratory analysis of selected population subgroups in DMIST. Radiology 2008; 246:376-383.